<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS Pathog</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plospath</journal-id>
<journal-title-group>
<journal-title>PLOS Pathogens</journal-title>
</journal-title-group>
<issn pub-type="ppub">1553-7366</issn>
<issn pub-type="epub">1553-7374</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.ppat.1006796</article-id>
<article-id pub-id-type="publisher-id">PPATHOGENS-D-17-00892</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Orthomyxoviruses</subject><subj-group><subject>Influenza viruses</subject><subj-group><subject>Influenza A virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Orthomyxoviruses</subject><subj-group><subject>Influenza viruses</subject><subj-group><subject>Influenza A virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Orthomyxoviruses</subject><subj-group><subject>Influenza viruses</subject><subj-group><subject>Influenza A virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Orthomyxoviruses</subject><subj-group><subject>Influenza viruses</subject><subj-group><subject>Influenza A virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Chemical compounds</subject><subj-group><subject>Organic compounds</subject><subj-group><subject>Amino acids</subject><subj-group><subject>Amino acid substitution</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Organic chemistry</subject><subj-group><subject>Organic compounds</subject><subj-group><subject>Amino acids</subject><subj-group><subject>Amino acid substitution</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Amino acids</subject><subj-group><subject>Amino acid substitution</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Glycobiology</subject><subj-group><subject>Glycosylation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Post-translational modification</subject><subj-group><subject>Glycosylation</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Mutation</subject><subj-group><subject>Substitution mutation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Immune physiology</subject><subj-group><subject>Antigens</subject><subj-group><subject>Antigenic variation</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Immune physiology</subject><subj-group><subject>Antigens</subject><subj-group><subject>Antigenic variation</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune system proteins</subject><subj-group><subject>Antigens</subject><subj-group><subject>Antigenic variation</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune system proteins</subject><subj-group><subject>Antigens</subject><subj-group><subject>Antigenic variation</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Immune system proteins</subject><subj-group><subject>Antigens</subject><subj-group><subject>Antigenic variation</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Immune physiology</subject><subj-group><subject>Antibodies</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Immune physiology</subject><subj-group><subject>Antibodies</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune system proteins</subject><subj-group><subject>Antibodies</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune system proteins</subject><subj-group><subject>Antibodies</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Immune system proteins</subject><subj-group><subject>Antibodies</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Microbial evolution</subject><subj-group><subject>Viral evolution</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Evolutionary biology</subject><subj-group><subject>Organismal evolution</subject><subj-group><subject>Microbial evolution</subject><subj-group><subject>Viral evolution</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Virology</subject><subj-group><subject>Viral evolution</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Microbial mutation</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs</article-title>
<alt-title alt-title-type="running-head">Epistatic glycosylation</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Kosik</surname>
<given-names>Ivan</given-names>
</name>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Ince</surname>
<given-names>William L.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-2532-412X</contrib-id>
<name name-style="western">
<surname>Gentles</surname>
<given-names>Lauren E.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6310-0434</contrib-id>
<name name-style="western">
<surname>Oler</surname>
<given-names>Andrew J.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Software</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-1433-3343</contrib-id>
<name name-style="western">
<surname>Kosikova</surname>
<given-names>Martina</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-3882-1504</contrib-id>
<name name-style="western">
<surname>Angel</surname>
<given-names>Matthew</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Software</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Magadán</surname>
<given-names>Javier G.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-8318-5554</contrib-id>
<name name-style="western">
<surname>Xie</surname>
<given-names>Hang</given-names>
</name>
<role content-type="http://credit.casrai.org/">Supervision</role>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6815-1193</contrib-id>
<name name-style="western">
<surname>Brooke</surname>
<given-names>Christopher B.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff005"><sup>5</sup></xref>
<xref ref-type="aff" rid="aff006"><sup>6</sup></xref>
<xref ref-type="fn" rid="econtrib001"><sup>‡</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-3826-1906</contrib-id>
<name name-style="western">
<surname>Yewdell</surname>
<given-names>Jonathan W.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="fn" rid="econtrib001"><sup>‡</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Cellular Biology Section, Laboratory of Viral Diseases, NIAID, Bethesda, Maryland, United States of America</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Center for Drug Evaluation and Research, FDA, Silver Spring, Maryland, United States of America</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Bioinformatics and Computational Biosciences Branch, Office of Cyber Infrastructure and Computational Biology, NIAID, Bethesda, Maryland, United States of America</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>Laboratory of Respiratory Viral Diseases, Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, FDA, Silver Spring, Maryland, United States of America</addr-line></aff>
<aff id="aff005"><label>5</label> <addr-line>Department of Microbiology, School of Molecular and Cellular Biology, University of Illinois, Urbana, Illinois, United States of America</addr-line></aff>
<aff id="aff006"><label>6</label> <addr-line>Carl R. Woese Institute for Genomic Biology, University of Illinois, Urbana, Illinois, United States of America</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Thomas</surname>
<given-names>Paul G.</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>St. Jude Children’s Research Hospital, UNITED STATES</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="other" id="econtrib001">
<p>‡ CBB and JWY also contributed equally to this work.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">cbrooke@illinois.edu</email> (CBB); <email xlink:type="simple">jyewdell@niaid.nih.gov</email> (JWY)</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>18</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<month>1</month>
<year>2018</year>
</pub-date>
<volume>14</volume>
<issue>1</issue>
<elocation-id>e1006796</elocation-id>
<history>
<date date-type="received">
<day>25</day>
<month>4</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>7</day>
<month>12</month>
<year>2017</year>
</date>
</history>
<permissions>
<license xlink:href="https://creativecommons.org/publicdomain/zero/1.0/" xlink:type="simple">
<license-p>This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/" xlink:type="simple">Creative Commons CC0</ext-link> public domain dedication.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.ppat.1006796"/>
<abstract>
<p>Rapid antigenic evolution enables the persistence of seasonal influenza A and B viruses in human populations despite widespread herd immunity. Understanding viral mechanisms that enable antigenic evolution is critical for designing durable vaccines and therapeutics. Here, we utilize the primerID method of error-correcting viral population sequencing to reveal an unexpected role for hemagglutinin (HA) glycosylation in compensating for fitness defects resulting from escape from anti-HA neutralizing antibodies. Antibody-free propagation following antigenic escape rapidly selected viruses with mutations that modulated receptor binding avidity through the addition of N-linked glycans to the HA globular domain. These findings expand our understanding of the viral mechanisms that maintain fitness during antigenic evolution to include glycan addition, and highlight the immense power of high-definition virus population sequencing to reveal novel viral adaptive mechanisms.</p>
</abstract>
<abstract abstract-type="summary">
<title>Author summary</title>
<p>Seasonal influenza A viruses (IAV) cause tens of thousands of deaths and tens of billions of dollars in economic costs every year in the U.S. alone, despite widespread pre-exposure and vaccination. IAV persists within the human population by evading herd immunity through the continual accumulation of immune escape substitutions in a process known as antigenic drift. Unfortunately, the specific mechanisms that facilitate IAV antigenic drift remain unclear, making it difficult to design more efficacious, escape-proof vaccines. Here, we used a high-definition population sequencing approach to understand how IAV tolerates the accumulation of immune escape substitutions during antigenic drift without losing fitness. We found that the virus rapidly acquired N-linked glycan structures on the hemagglutinin (HA) protein following escape from a panel of neutralizing antibodies. Glycosylation of HA alleviated the deleterious effects of immune escape substitutions on interactions with host cell receptors. These results expand our understanding of the mechanisms that facilitate IAV immune evasion, and highlight the immense power of high-definition virus population sequencing to reveal novel viral adaptive mechanisms.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100006492</institution-id>
<institution>Division of Intramural Research, National Institute of Allergy and Infectious Diseases</institution>
</institution-wrap>
</funding-source>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-3826-1906</contrib-id>
<name name-style="western">
<surname>Yewdell</surname>
<given-names>Jonathan W.</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>All work funded directly by US gov′t. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="6"/>
<table-count count="1"/>
<page-count count="19"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>Influenza A virus (IAV) persists in human populations by continuously evolving to escape herd immunity. Protective immunity is predominantly mediated by neutralizing antibodies (Abs) specific for the viral surface glycoprotein hemagglutinin (HA). HA mediates both target cell attachment, by binding terminal sialic acids (SA) on cellular membrane components, and fusion between viral and cellular membranes following virion internalization. Neutralizing Abs mainly target the five highly variable immunodominant antigenic sites on the globular head domain of HA, blocking either HA-mediated attachment or fusion [<xref ref-type="bibr" rid="ppat.1006796.ref001">1</xref>–<xref ref-type="bibr" rid="ppat.1006796.ref004">4</xref>]. Viruses can escape neutralization by amino substitutions in HA that reduce antibody affinity and/or function. The fitness costs imposed by Ab escape, and the mechanisms by which the virus compensates remain poorly understood, yet play a central role in governing HA antigenic evolution [<xref ref-type="bibr" rid="ppat.1006796.ref005">5</xref>,<xref ref-type="bibr" rid="ppat.1006796.ref006">6</xref>].</p>
<p>Influenza virus escapes from neutralizing antibody via a number of defined mechanisms involving HA mutations. The simplest is an amino acid substitution in a cognate epitope that diminishes antibody affinity [<xref ref-type="bibr" rid="ppat.1006796.ref002">2</xref>]. Less commonly, distant substitutions can affect antibody binding via allosteric effects on antibody access to its epitope [<xref ref-type="bibr" rid="ppat.1006796.ref007">7</xref>–<xref ref-type="bibr" rid="ppat.1006796.ref009">9</xref>]. Amino acid substitutions in the sialic acid receptor site, or other regions of the globular domain that increase affinity for cellular SA receptors, enable Ab-escape by shifting the binding equilibrium towards virus binding to cells <italic>versus</italic> antibody [<xref ref-type="bibr" rid="ppat.1006796.ref010">10</xref>–<xref ref-type="bibr" rid="ppat.1006796.ref013">13</xref>]. The most drastic alterations in overall antigenicity typically result from amino acid substitutions that create a N-linked glycosylation site in the globular domain, as the attached glycan can sterically block the binding of Abs to multiple sites [<xref ref-type="bibr" rid="ppat.1006796.ref005">5</xref>,<xref ref-type="bibr" rid="ppat.1006796.ref014">14</xref>–<xref ref-type="bibr" rid="ppat.1006796.ref019">19</xref>].</p>
<p>The ability of viruses to exploit these escape routes is limited by their costs to viral fitness. The sialic acid receptor binding site is nestled among the immunodominant antigenic sites, and escape substitutions often alter viral fitness by changing HA receptor binding avidity. Amino acid substitutions that change the net charge of the globular domain typically alter cell binding avidity [<xref ref-type="bibr" rid="ppat.1006796.ref013">13</xref>,<xref ref-type="bibr" rid="ppat.1006796.ref020">20</xref>]. We previously demonstrated that selection of substitutions that add N-linked glycosylation sites within the globular domain to escape antibody neutralization often reduces receptor avidity [<xref ref-type="bibr" rid="ppat.1006796.ref005">5</xref>]. Receptor avidity and HA antigenicity are thus intimately linked, and must be continuously balanced to maintain fitness during antigenic evolution [<xref ref-type="bibr" rid="ppat.1006796.ref013">13</xref>,<xref ref-type="bibr" rid="ppat.1006796.ref021">21</xref>].</p>
<p>Here, we use the primerID method for error-correcting virus population sequencing to reveal a surprising new role for N-linked glycosylation in facilitating IAV immune escape. Beyond its canonical role in blocking Ab binding, we show that glycosylation can also compensate for fitness costs imposed by escape substitutions elsewhere on HA, thus increasing the viability and subsequent emergence potential of Ab-escape variants.</p>
</sec>
<sec id="sec002" sec-type="results">
<title>Results</title>
<sec id="sec003">
<title>HA Ab escape mutations reduce viral fitness in the absence of Ab pressure</title>
<p>We previously modeled IAV antigenic evolution by sequentially selecting for virus escape from different mouse anti-HA monoclonal Abs (mAbs) under over-neutralizing conditions using the allantois-on-shell (AOS) system [<xref ref-type="bibr" rid="ppat.1006796.ref021">21</xref>]. Twelve rounds of mAb escape by PR8 yielded a virus (SV12) carrying twelve amino acid substitutions in HA that collectively mediated near total escape from polyclonal serum raised against PR8 in mice, guinea pigs or chickens. When propagated in embryonated chicken eggs, PR8 and SV12 reached similar titers in the absence of Ab pressure, suggesting that the selected constellation of escape mutations imposed minimal fitness costs on the virus.</p>
<p>An alternative possibility that we did not examine in detail is that the accumulation of antigenic escape substitutions imposed significant costs, but strong selection for compensatory mutations or reversions in SV12 rapidly restored fitness during the initial rounds of SV12 expansion in eggs; the original SV12 isolate had been expanded 2–3 times in the absence of antibody in embryonated chicken eggs after the 12<sup>th</sup> sequential selection in the AOS system [<xref ref-type="bibr" rid="ppat.1006796.ref021">21</xref>]. To test this possibility, we generated a recombinant PR8 clone carrying the consensus SV12 HA gene segment and compared the ability of WT PR8 and the consensus SV12 clone to replicate in eggs (<xref ref-type="fig" rid="ppat.1006796.g001">Fig 1</xref>). This revealed that antigenic escape substitutions present within SV12 HA imposed significant fitness costs (greater than 10-fold decreased titer) when the virus population had limited time to recover fitness via mutational compensation.</p>
<fig id="ppat.1006796.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1006796.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Fitness tradeoff associated with the accumulation of antigenic escape substitutions in HA.</title>
<p>Growth of plaque purified biological clones of PR8 WT and SV12 was compared in eggs. Eggs were infected in triplicate with 500 TCID50 of the indicated virus. 48 hours later, viral loads in allantoic cavities were titered by TCID50 assay.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006796.g001" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec004">
<title>High resolution examination of IAV mutational spectra using primerID sequencing</title>
<p>Compensatory mutations that increased the fitness of SV12 may not have been identified with conventional Sanger sequencing if multiple variants were selected that collectively were a significant proportion of the population, but that individually remained below the wild-type SV12 consensus frequency at each codon. To identify compensatory mutations or reversions in HA that potentially emerged following sequential antigenic escape, we used the primerID method for error-correcting virus population sequencing to identify minor sequence variants that emerged during the limited expansion passaging of SV12 [<xref ref-type="bibr" rid="ppat.1006796.ref022">22</xref>,<xref ref-type="bibr" rid="ppat.1006796.ref023">23</xref>].</p>
<p>PrimerID sequencing is based on tagging individual viral cDNAs with random unique sequence barcodes during reverse transcription [<xref ref-type="bibr" rid="ppat.1006796.ref022">22</xref>,<xref ref-type="bibr" rid="ppat.1006796.ref023">23</xref>]. These barcodes are maintained through downstream PCR and sequencing steps and are used to assemble all sequencing reads derived from a single cDNA sequence. This permits consensus-based reconstruction of the original cDNA sequence, enumeration of actual viral genomes sampled, and analysis of linkage between specific mutations within reads. Importantly, primerID lowers the background sequencing error rate of the Illumina platform 10-100-fold (to 10<sup>−3</sup>–10<sup>−4</sup> non-consensus events/nt), by correcting the high-frequency PCR and base-calling errors that occur during standard next-generation sequencing. PrimerID can also correct for variant frequency skewing due to PCR resampling imbalance [<xref ref-type="bibr" rid="ppat.1006796.ref022">22</xref>,<xref ref-type="bibr" rid="ppat.1006796.ref023">23</xref>].</p>
<p>To precisely quantify the advantages conferred by primerID sequencing over shotgun sequencing approaches in the context of IAV population sequencing, we directly compared results obtained with the primerID method to those obtained by shotgun sequencing, as analyzed through the ViVan pipeline [<xref ref-type="bibr" rid="ppat.1006796.ref024">24</xref>]. Variant calls with a moderately high frequency (&gt;10<sup>−3</sup>) show consistent results whether an amplicon/primerID or a shotgun sequencing approach were used (<xref ref-type="supplementary-material" rid="ppat.1006796.s001">S1 Fig</xref>); however, evaluating variant frequencies in the range of 10<sup>−4</sup> to 10<sup>−3</sup> shows that primerID gives a higher signal to background noise ratio compared to shotgun sequencing (<xref ref-type="supplementary-material" rid="ppat.1006796.s002">S2 Fig</xref>). The noise reduction of primerID consensus reads compared to unmerged amplicon reads ranges from 9.2-fold to 18.9-fold (<xref ref-type="supplementary-material" rid="ppat.1006796.s004">S1 Table</xref>). Similarly, the background noise level, estimated by the median combined minor allele frequency (MAF) in primerID is about 3-10x10<sup>-5</sup>, which is 4.5 to 12-fold lower than background in shotgun sequencing (<xref ref-type="supplementary-material" rid="ppat.1006796.s005">S2 Table</xref>). Altogether, primerID allows for more conservative variant calling, and likely more accurate estimations of variant frequencies, than algorithm-based error correction approaches [<xref ref-type="bibr" rid="ppat.1006796.ref024">24</xref>,<xref ref-type="bibr" rid="ppat.1006796.ref025">25</xref>].</p>
</sec>
<sec id="sec005">
<title>PrimerID population sequencing reveals the rapid emergence of compensatory variants following antigenic escape</title>
<p>To identify emergent HA variants within an approximately 143 a.a. region (115 to 258) that encompassed the receptor binding pocket and most of the SV12 substitutions in the original expanded SV12 virus stock, we performed paired-end sequencing of primerID libraries on the Illumina MiSeq platform and analyzed data using a custom software pipeline. Sequencing revealed amino acid substitutions at 7 sites that emerged at frequencies of &gt;0.1% during 2–3 passages of SV12. These substitutions were (including their frequencies) K123N (1.7%), K123E (1.1%), N133T (25%), N133S (8%), K144N (9%), K144E (0.5%), N145D (0.3%), K174E (0.3%), K222T (0.17%), and G225D (3.7%) (all H3 HA numbering) (<xref ref-type="fig" rid="ppat.1006796.g002">Fig 2A</xref>). Linkage analysis revealed that substitutions at positions K123, N133, K144, K145, and G225 represented distinct variants (<xref ref-type="supplementary-material" rid="ppat.1006796.s005">S2 Table</xref>), and thus collectively made up approximately 50% of the population of the SV12 stock.</p>
<fig id="ppat.1006796.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1006796.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Identification of variants that emerge on the SV12 background after passage in eggs in the absence of antibody.</title>
<p><bold>(A)</bold> Amino acid variant frequencies within SV12 HA following limited passage in eggs, as determined by primerID sequencing. Red and black data points represent frequencies obtained from two stocks separately expanded one time in eggs prior to sequencing. Amino acid positions with &gt;0.1% variability (dashed line) in both stocks are labeled with the most abundant substitution at the position. Codons 184–186 were not captured by sequencing. <bold>(B)</bold> HA structure (PDB 1RU7) with the SV12-defining substitutions (red) and emerging amino acid substitutions (labeled in 2A) (blue) highlighted. The black stick model represents sialic acid situated in the receptor binding pocket.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006796.g002" xlink:type="simple"/>
</fig>
<p>Each substitution was observed at sites with potential functional roles in SV12 (<xref ref-type="fig" rid="ppat.1006796.g002">Fig 2B</xref>). Substitutions at two SV12-defining sites were observed: G225D was a reversion to the PR8 wild-type amino acid identity, while the most abundant substitution at N145 was D (0.3%), rather than the PR8 wild-type S (0.01%). The other substitutions (K123N/E, N133T/S, K144N/E, K174E, and K222T) were at new sites, but were adjacent to SV12-defining sites or rimmed the receptor binding site (<xref ref-type="fig" rid="ppat.1006796.g002">Fig 2B</xref>). Thus, a combination of forward mutations and reversions rapidly emerged on the SV12 background following antigenic escape.</p>
</sec>
<sec id="sec006">
<title>The addition of N-linked glycans to HA can compensate for the fitness costs of antigenic escape</title>
<p>Three of the amino acid substitutions that emerged in the original expanded SV12 virus stock (K123N, N133T, and K144N) created new potential N-linked glycan sites (PNGS) within the HA sequence (at positions 123, 131 and 144, respectively). To determine whether these substitutions indeed affected the glycosylation status of virion-associated HA[<xref ref-type="bibr" rid="ppat.1006796.ref026">26</xref>], we introduced each substitution individually into the recombinant consensus SV12 HA background (rSV12-HA) and rescued viruses carrying the 7 other gene segments from WT PR8 by reverse genetics. We generated purified, detergent-disrupted virus preparations of rSV12-HA, rSV12(K123N)-HA, rSV12(N133T)-HA, and rSV12(K144N)-HA and digested with either Endo H (cleaves mannose-rich N-linked glycans, but not complex N-linked glycans) or PNGase F (cleaves all N-linked glycans). We compared the migration of digested and undigested HA on a denaturing gel by immunoblotting (<xref ref-type="fig" rid="ppat.1006796.g003">Fig 3A</xref>). All three compensatory PNGS clearly slowed the migration of undigested, but not PNGase F-digested, HA on the gel, demonstrating that each mutation results in the addition of a glycan chain to virion-associated HA.</p>
<fig id="ppat.1006796.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1006796.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Characterization of compensatory glycan additions.</title>
<p><bold>(A)</bold> Western blot comparison of HA glycosylation mutants following endoglycosidase treatment. Treatment 1 = undigested, treatment 2 = Endo H digested, treatment 3 = PNGase digested. <bold>(B)</bold> Growth comparison of PR8, SV12, and SV12 plus individual compensatory mutations in eggs. Eggs were inoculated with 500 TCID50, and viral loads within allantoic cavities were assessed by TCID50 assay at the indicated time points.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006796.g003" xlink:type="simple"/>
</fig>
<p>We next tested whether compensatory glycosylation site additions increased the replicative capacity of rSV12-HA in multi-step growth assays in eggs (<xref ref-type="fig" rid="ppat.1006796.g003">Fig 3B</xref>). The impact of K144N on titer was marginal, but K123N and N133T both resulted in 10–100 fold higher viral titers compared with parental rSV12-HA virus by 36 hpi, demonstrating a clear role for each of these glycosylation site additions in restoring fitness in eggs following SV12 antigenic escape.</p>
</sec>
<sec id="sec007">
<title>Glycan addition partially restores wild-type receptor binding characteristics following antigenic escape</title>
<p>A clue to how these glycan additions restore SV12 fitness came from their close proximity to the HA receptor binding pocket (<xref ref-type="fig" rid="ppat.1006796.g002">Fig 2B</xref>). We hypothesized that the glycans modulate HA receptor binding avidity, correcting for detrimental effects of escape substitutions. To test this, we compared the association (<italic>K</italic><sub>on</sub>) and dissociation (<italic>K</italic><sub><italic>off</italic></sub>) rates of purified WT PR8, rSV12-HA, rSV12(K123N)-HA, rSV12(N133T)-HA, and rSV12(K144N)-HA virion preps binding to the model sialic acid receptor 3-SLN using bio-layer interferometry (BLI) (<xref ref-type="fig" rid="ppat.1006796.g004">Fig 4</xref>, <xref ref-type="table" rid="ppat.1006796.t001">Table 1</xref>). rSV12-HA exhibited a 3-fold increase in binding avidity, compared with WT HA. The addition of the K123N, and N133T substitutions to SV12 HA altered binding constants toward WT levels, consistent with our hypothesis. The K144N substitution reduced binding avidity to a much greater degree than K123N or N133T, resulting a 2-fold decrease in avidity relative to WT HA. This effect may have crossed a line beyond the beneficial effects of K123N and N133T, resulting in a detrimental loss of binding avidity (compared with WT) that may explain the comparatively slower growth kinetics of the K144N variant (<xref ref-type="fig" rid="ppat.1006796.g003">Fig 3B</xref>).</p>
<fig id="ppat.1006796.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1006796.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Bio-layer interferometry comparison of binding properties of WT, SV12 and SV12-N133T.</title>
<p>To measure binding properties of WT PR8, SV12, and the compensatory glycan addition mutant N133T, we bound biotinylated 3’SLN to sensor at different concentrations, and measured the K<sub>on</sub> and K<sub>off</sub> of intact purified virions in the presence and absence of the NA inhibitor oseltamivir, respectively. We fit two-phase (association then dissociation) nonlinear regression curves based on the average of 2–3 experiments.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006796.g004" xlink:type="simple"/>
</fig>
<table-wrap id="ppat.1006796.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1006796.t001</object-id>
<label>Table 1</label> <caption><title>Bio-layer interferometry analysis of HA compensatory glycans.</title></caption>
<alternatives>
<graphic id="ppat.1006796.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006796.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left"/>
<th align="center">3’SLN K<sub>on</sub> [nM<sup>-1</sup>.ms<sup>-1</sup>]</th>
<th align="center">3’SLN K<sub>off</sub> [μs<sup>-1</sup>]</th>
<th align="center">3’SLN Apparent K<sub>D</sub> [pM]</th>
<th align="center">3’SLN R<sup>2</sup></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left"><bold>PR8</bold></td>
<td align="left">8.36±0.6</td>
<td align="left">8.56±3.55</td>
<td align="left">1.02±0.58</td>
<td align="char" char=".">0.98</td>
</tr>
<tr>
<td align="left"><bold>K123N</bold></td>
<td align="left"><bold>14.38±1.36</bold></td>
<td align="left"><bold>8.34±1.36</bold></td>
<td align="left"><bold>0.44±0.24</bold></td>
<td align="char" char="."><bold>0.99</bold></td>
</tr>
<tr>
<td align="left"><bold>N133T</bold></td>
<td align="left">13.53±1.14</td>
<td align="left">10.62±2.52</td>
<td align="left">0.8±0.25</td>
<td align="char" char=".">0.98</td>
</tr>
<tr>
<td align="left"><bold>K144N</bold></td>
<td align="left"><bold>4.56±0.02</bold></td>
<td align="left"><bold>9.59±2.18</bold></td>
<td align="left"><bold>2.1±0.49</bold></td>
<td align="char" char="."><bold>0.95</bold></td>
</tr>
<tr>
<td align="left"><bold>N133T/K144N</bold></td>
<td align="left">16.38±0.54</td>
<td align="left">13.95±1.91</td>
<td align="left">0.85±0.13</td>
<td align="char" char=".">0.96</td>
</tr>
<tr>
<td align="left"><bold>SV12</bold></td>
<td align="left">3.78±0.27</td>
<td align="left">1.22±0.61</td>
<td align="left">0.32±0.22</td>
<td align="char" char=".">0.94</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
</sec>
<sec id="sec008">
<title>Similar repertoires of compensatory mutations emerge during independent experiments</title>
<p>To determine the reproducibility (and potentially the predictability) of the compensatory mechanisms that we observed, we repeated the passage experiment using recombinant, reverse genetics-derived versions of either WT PR8 or SV12-HA (rSV12-HA) virus as the parental virus. We generated each virus in 293T cells from transfected plasmids and then passaged each virus in triplicate in chicken eggs, using a dose of 10<sup>4</sup> EID<sub>50</sub> (based on allantois-on-shell infectivity) to initiate each passage. We harvested each passage at 16 hours post-infection (h.p.i.) to minimize defective interfering particle formation. After the third passage, we sequenced the entire HA coding region of all six passaged populations, along with the parental seed stocks, using an optimized primerID protocol, (see <xref ref-type="sec" rid="sec011">Methods</xref>). To overcome the sequence read length limitations of the Illumina Miseq platform (&lt;550nt read length limit), we used four amplicons to cover the entire HA coding region.</p>
<p>Both SV12 and PR8 (WT) parental populations harbored numerous missense mutations at frequencies above background in HA (<xref ref-type="fig" rid="ppat.1006796.g005">Fig 5A</xref>). Five such mutations resulted in amino acid substitutions that were present in the WT PR8 parental population at frequencies over 0.1%, with a K123T substitution dominant at 2.5% (<xref ref-type="fig" rid="ppat.1006796.g005">Fig 5B</xref>). Four of the WT variants likely emerged due to stochastic genetic drift resulting from bottlenecking during the rescue process, as indicated by minimal change in frequency by passage 3 [<xref ref-type="bibr" rid="ppat.1006796.ref027">27</xref>]. One variant enriched in the WT parental population, K174E, increased slightly in frequency in all three passage lines, and may represent a tissue culture adaptive variant as it was also present in the parental rSV12-HA population. No other variants exhibited a consistent pattern of emergence during passaging of the WT populations.</p>
<fig id="ppat.1006796.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1006796.g005</object-id>
<label>Fig 5</label>
<caption>
<title>PrimerID sequencing of HA genes from recombinant WT and SV12-HA following passage.</title>
<p>Recombinant PR8 (WT) and rSV12-HA (SV12) viruses were rescued via reverse genetics. <bold>(A)</bold> Amino acid variant frequencies within WT (black) and SV12 HA (red) populations collected from rescue supernatants without amplification, as determined by primerID sequencing. (<bold>B,C</bold>) Amino acid variant frequencies within WT <bold>(B)</bold> and rSV12-HA <bold>(C)</bold> populations following three passages in eggs. For each population, all variants over 0.1% are colored to allow them to be visually distinguished. <bold>(D)</bold> Comparison of amino acid variant frequencies within rSV12-HA populations before and after 3 passages in eggs. Passage 3 data represents mean +/- SD of three independent passage lines. All amino acid numbering indicated on graphs <bold>A-C</bold> is from initiating methionine, not according to H3 system.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006796.g005" xlink:type="simple"/>
</fig>
<p>By contrast, the parental rSV12-HA population carried nearly three times as many missense mutations (14 vs. 5) at frequencies &gt;0.1% (<xref ref-type="fig" rid="ppat.1006796.g005">Fig 5C</xref>), primarily located in the globular domain of HA. Only K174E was also present in the WT parental population. Five of the 14 variants increased or were maintained at high frequency during passaging in all three SV12 populations: N133T, T136S, K144E, N145D, and G225D (<xref ref-type="fig" rid="ppat.1006796.g005">Fig 5D</xref>). Of these, N133T exhibited the most dramatic increase in frequency and approached fixation in all three passage lines. Strikingly, four of the five variants carried substitutions at residues that had elevated variant frequencies in our first experiment: N133, K144, N145, and G225, indicating that compensation for antigenic escape can follow predictable genetic pathways under highly controlled conditions.</p>
</sec>
<sec id="sec009">
<title>Linkage analysis reveals near mutual exclusivity among compensatory substitutions during passage</title>
<p>Emergence of an amino acid variant within a population may result from positive selection driven by specific beneficial effects of the variant on fitness. Alternatively, the variant may be neutral or deleterious but hitchhike with another variant under positive selection to attain higher frequency. The potential for intragenic hitchhiking is high with IAV due to extreme rarity of intragenic recombination during infection [<xref ref-type="bibr" rid="ppat.1006796.ref028">28</xref>]. PrimerID sequencing allows the direct quantification of linkage between amino acid positions present in individual viral cDNAs, thereby defining the relative contributions of direct selection <italic>vs</italic>. hitchhiking in amino acid variant emergence.</p>
<p>We assessed the extent of genetic linkage between the five high frequency variants that emerged in all three rSV12-HA passage populations (N133T, T136S, K144E, N145D, and G225D) (<xref ref-type="fig" rid="ppat.1006796.g005">Fig 5D</xref>). Examination of linkage at passage 3 revealed that 4 of the variants, N133T, K144E, N145D, and G225D, were mutually exclusive within single HA variants (with just a handful of exceptions) (<xref ref-type="fig" rid="ppat.1006796.g006">Fig 6A</xref>, <xref ref-type="supplementary-material" rid="ppat.1006796.s006">S3</xref> and <xref ref-type="supplementary-material" rid="ppat.1006796.s007">S4</xref> Tables). In contrast, T136S was only observed as paired with N133T. These results were consistent with the nearly mutually exclusive relationships determined for the substitutions observed in the first sequencing experiment carried out on the original SV12 stock (<xref ref-type="fig" rid="ppat.1006796.g002">Fig 2</xref>, <xref ref-type="supplementary-material" rid="ppat.1006796.s005">S2 Table</xref>).</p>
<fig id="ppat.1006796.g006" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1006796.g006</object-id>
<label>Fig 6</label>
<caption>
<title>Linkage analysis of high frequency variants that emerged during rSV12-HA passage.</title>
<p><bold>(A)</bold> Graphical representation of genetic linkage between selected variants within the three parallel passage 3 rSV12-HA populations, based on PrimerID sequencing. Node size is proportional to relative frequency of the indicated allele across the three populations. Aqua nodes indicate parental amino acids and red nodes represent variant amino acids. Edges connect pairs of amino acids that were linked in greater than 0.02% of all primerID consensus reads examined. <bold>(B)</bold> Multi-step growth comparison of the indicated viruses in eggs.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006796.g006" xlink:type="simple"/>
</fig>
<p>These findings suggest that each emergent, mutually-exclusive substitution was selected individually for its ability to compensate for the fitness defects of SV12, and that their combination in the same variant may substantially reduce fitness. The data, however, are also consistent with the predicted infrequent recombination within IAV genome segments and a strong role for clonal interference in governing the emergence of beneficial alleles during adaptation [<xref ref-type="bibr" rid="ppat.1006796.ref029">29</xref>,<xref ref-type="bibr" rid="ppat.1006796.ref030">30</xref>].</p>
<p>To test whether combining compensatory HA glycan additions decreases viral fitness, we generated a N133T, K144N double mutant (rSV12(N133T, K144N)) using reverse genetics. After confirming the double mutant did incorporate an additional glycan compared to the single mutants by SDS-PAGE (<xref ref-type="supplementary-material" rid="ppat.1006796.s003">S3 Fig</xref>), we examined its growth in eggs. The double mutant achieved significantly higher titers than rSV12-HA, but lower than rSV12(N133T) (<xref ref-type="fig" rid="ppat.1006796.g006">Fig 6B</xref>). This result can be explained by the binding activity of the double mutant, which is comparable to rSV12(N133T) based on BLI (<xref ref-type="table" rid="ppat.1006796.t001">Table 1</xref>). Together, these data suggest that clonal interference rather than reduced fitness may be the primary explanation for the mutual exclusivity of compensatory substitutions that we observe.</p>
</sec>
</sec>
<sec id="sec010" sec-type="conclusions">
<title>Discussion</title>
<p>IAV has persisted in humans despite widespread vaccination and infection, while vaccination has driven other RNA viruses with similarly high mutation rates, such as measles virus and poliovirus, to near-extinction. Understanding the specific features of IAV that enable effective immune escape is critical for designing more effective vaccines and therapeutics.</p>
<p>Our findings reveal a novel role for glycosylation in viral immune evasion, independent of its well-known steric effects on epitope shielding [<xref ref-type="bibr" rid="ppat.1006796.ref014">14</xref>–<xref ref-type="bibr" rid="ppat.1006796.ref019">19</xref>]. Previous studies clearly showed that glycan addition generally impairs HA function while dramatically increasing fitness in the presence of neutralizing antibodies [<xref ref-type="bibr" rid="ppat.1006796.ref005">5</xref>]. Our results demonstrate that glycan addition can also play the opposite role during antigenic drift: increasing the fitness of antigenic escape variants by restoring optimal HA receptor interactions, even in the absence of antibody selective pressure. This raises the intriguing possibility that both mechanisms contribute to the steady evolutionary accretion of N-linked glycans within the globular domain observed during human circulation of H1 and H3 viruses [<xref ref-type="bibr" rid="ppat.1006796.ref017">17</xref>].</p>
<p>Importantly, the fact that we selected for glycan addition in the absence of Ab selection does not diminish the profound effects that these glycans have on the antigenicity of HA. In particular, the predominant variant selected, N133S/T, also emerged during the circulation of seasonal H1N1 in humans, and has been demonstrated to have enormous effects on antigenicity and sensitivity to neutralization [<xref ref-type="bibr" rid="ppat.1006796.ref017">17</xref>]. These results highlight the self-perpetuating nature of HA antigenic evolution. Hensley et al. found that infection of naïve hosts with antigenic escape variants selected for compensatory mutations that were themselves antigenically significant [<xref ref-type="bibr" rid="ppat.1006796.ref013">13</xref>]. Similarly, our results demonstrate that antigenic escape can lead to the emergence of compensatory mutations that push HA even further in antigenic space. These factors make it difficult to infer the nature of selective pressures resulting in given HA sequence changes in human IAV isolates.</p>
<p>Defining the specific properties of the HA molecule that facilitate mutational tolerance is an area of intense study. Studies <italic>in vitro</italic> found that the HA globular head was highly tolerant of both random substitutions and 5-amino acid block insertions [<xref ref-type="bibr" rid="ppat.1006796.ref003">3</xref>,<xref ref-type="bibr" rid="ppat.1006796.ref027">27</xref>,<xref ref-type="bibr" rid="ppat.1006796.ref031">31</xref>,<xref ref-type="bibr" rid="ppat.1006796.ref032">32</xref>]. These results suggested that the HA globular head may exhibit a high degree of mutational robustness, such that the median fitness effects of substitutions are relatively small [<xref ref-type="bibr" rid="ppat.1006796.ref032">32</xref>–<xref ref-type="bibr" rid="ppat.1006796.ref034">34</xref>]. Alternatively, mutations may generally be costly, but are compensated by epistatic mutations that restore protein function and fitness[<xref ref-type="bibr" rid="ppat.1006796.ref006">6</xref>,<xref ref-type="bibr" rid="ppat.1006796.ref035">35</xref>]. Our data, along with other studies that demonstrate fitness costs associated with antigenic variation and/or rapid emergence of compensatory mutations following HA antigenic escape, suggest that compensatory epistatic interactions play a critical role during antigenic drift [<xref ref-type="bibr" rid="ppat.1006796.ref006">6</xref>,<xref ref-type="bibr" rid="ppat.1006796.ref013">13</xref>,<xref ref-type="bibr" rid="ppat.1006796.ref036">36</xref>,<xref ref-type="bibr" rid="ppat.1006796.ref037">37</xref>].</p>
<p>If rapid compensation of antigenic escape mutations is important for maintaining fitness during antigenic drift, then defining compensatory mechanisms is essential. Many antigenicity-determining residues scattered in the HA globular domain also strongly influence avidity and specificity for sialic acid receptors, and thus Ab escape substitutions at these residues can negatively affect receptor interactions[<xref ref-type="bibr" rid="ppat.1006796.ref013">13</xref>]. As a result, many of the compensatory mutations that have been described in association with antigenic escape affect receptor interactions, and likely serve to restore optimal receptor binding properties. The need to accumulate compensatory mutations in order to combine antigenic novelty with fitness and transmissibility has been proposed as an explanation for the discordance between the high <italic>in vitro</italic> mutation rates and rapid Ab-based selection of influenza viruses <italic>in vivo</italic> and the relatively slow rates of population-level antigenic evolution seen with influenza viruses[<xref ref-type="bibr" rid="ppat.1006796.ref013">13</xref>,<xref ref-type="bibr" rid="ppat.1006796.ref038">38</xref>]. Our results indicate that glycosylation can play an important role in this process.</p>
<p>The availability of multiple mutational pathways to restore fitness increases the odds that a fit variant will emerge under selection [<xref ref-type="bibr" rid="ppat.1006796.ref039">39</xref>]. Our discovery that glycan addition beneficially tunes receptor interactions adds to previously described mechanisms, including charge transitions in the globular HA domain and alterations in NA activity [<xref ref-type="bibr" rid="ppat.1006796.ref013">13</xref>,<xref ref-type="bibr" rid="ppat.1006796.ref021">21</xref>,<xref ref-type="bibr" rid="ppat.1006796.ref036">36</xref>,<xref ref-type="bibr" rid="ppat.1006796.ref040">40</xref>]. While difficult to test experimentally, it is intriguing to consider that IAV may have evolved to maximize the number of compensatory pathways available during antigenic drift.</p>
<p>Our unexpected discovery of a new role for glycosylation in compensating for IAV immune evasion highlights the power of virus population sequencing for uncovering novel mechanisms of viral adaptation through high-definition forward genetics screening. The ability to accurately measure changes in the viral population through methods such as primerID can provide a comprehensive, unbiased profile of the genetic pathways to increased fitness under defined selection conditions.</p>
<p>The primerID approach offers several advantages over conventional deep sequencing protocols. <italic>First</italic>, the ability to generate a multi-read consensus of the original cDNA sequence reduces the background nucleotide error rate from ~1% to ~0.01%, greatly increasing the sensitivity of minor variant detection. In theory, this background represents the <italic>bona fide</italic> mutation frequency within the population, combined with the mutation rate of the reverse transcriptase used to generate the cDNA pool (~0.01%)[<xref ref-type="bibr" rid="ppat.1006796.ref023">23</xref>]. <italic>Second</italic>, assembly of amplicon reads into ancestral cDNA sequences eliminates the distortion of measured variant frequencies by the stochastic PCR re-sampling that occurs during conventional amplicon sequencing. <italic>Third</italic>, the number of unique primerID barcodes used to generate consensus sequences represents the actual depth of the viral population sequenced. <italic>Fourth</italic>, the ability to phase substitutions into authentic haplotypes enables quantitation of linkage between substitutions within a given genome segment. Finally, primerID requires far less virus input than other methods of highly accurate population sequencing such as CirSeq, facilitating a wider range of experimental applications, including the analysis of samples collected from infected animals or human subjects [<xref ref-type="bibr" rid="ppat.1006796.ref041">41</xref>,<xref ref-type="bibr" rid="ppat.1006796.ref042">42</xref>].</p>
<p>Altogether, we reveal a surprising new role for glycosylation in facilitating IAV immune evasion by compensating for the fitness costs of antigenic escape mutations. These results broaden our understanding of the critical function of glycosylation during antigenic drift and shed light on the unique mutational plasticity of influenza HA. Further, these studies highlight the remarkable potential of highly accurate virus population sequencing and high-definition forward genetics for exploring viral evolution.</p>
</sec>
<sec id="sec011" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="sec012">
<title>Ethics</title>
<p>We obtained chicken eggs from a commercial vendor.</p>
</sec>
<sec id="sec013">
<title>Viruses</title>
<p>The original SV12 stock was generated as previously described [<xref ref-type="bibr" rid="ppat.1006796.ref021">21</xref>], and passaged 2–3 times in eggs in the absence of antibodies prior to RNA extraction and sequencing. We generated the A/Puerto Rico/8/1934 (PR8) strain using the eight-plasmid rescue system (plasmids generously provided by Dr. Adolfo Garcia-Sastre; Icahn School of Medicine at Mt. Sinai, New York). We generated seed virus by cotransfecting 293T cells (obtained from ATCC) with the eight gene segment-encoding plasmids. Seed virus stocks were expanded once in 10-day-old embryonated, specific pathogen-free (SPF) eggs. Allantoic fluid was collected 48 hours post infection, and clarified by centrifugation. A reverse genetic construct expressing the consensus HA gene segment sequence from SV12 was generated by RT-PCR amplification of the HA-encoding segment from SV12 virions, and cloning it into the pDZ vector. Virus mutants were generated by site-directed PCR mutagenesis of the relevant reverse genetics constructs. All infectious virus titers were determined by end-point dilution on MDCK cells (obtained from ATCC) in Gibco minimal essential medium (MEM) supplemented with 1 μg/mL trypsin treated with l-(tosylamido-2-phenyl) ethyl chloromethyl ketone (TPCK-treated trypsin), 1mM HEPES buffer (Corning), and gentamycin. TCID<sub>50</sub> titers were determined using the Reed–Muench method.</p>
</sec>
<sec id="sec014">
<title>Comparison of viral growth kinetics</title>
<p>To compare peak titers of molecular clone-derived mutants, 500 TCID<sub>50</sub> of each virus were inoculated into 10 day old embryonated eggs in triplicate. Allantoic fluid was collected 48 hours post infection, and titers determined based on end-point dilution using MDCK cells as described above.</p>
</sec>
<sec id="sec015">
<title>HA glycan analysis</title>
<p>MCDK cells were infected with rSV12-HA and each molecular clone-derived mutant at an MOI of 5 TCID<sub>50</sub>/cell. After 1 hour, virus supernatant was removed and replaced with Gibco MEM supplemented with 7.5% fetal bovine serum, after washing cells with PBS containing CaCl<sub>2</sub> and MgCl<sub>2</sub>. Six hours post infection, cells were washed twice with PBS, and then exposed to lysis buffer containing 1% sodium dodecyl sulfate, 50mM Tris-HCl pH 7.5, 10mM dithiothreitol (DTT), 15U/mL DNase1, and mini-complete protease inhibitor. Lysate was then digested either with EndoH or PNGase F or left untreated. Control or digested lysates were then immunoblotted using the mouse HA2 chain specific mAb RA5-22[<xref ref-type="bibr" rid="ppat.1006796.ref043">43</xref>].</p>
</sec>
<sec id="sec016">
<title>Passaging experiments</title>
<p>Recombinant PR8 and SEQ12HA viruses were serially passaged three times in 10-day old embryonated chicken eggs (Charles River) at a titer of 10<sup>4</sup> AOS ID/egg at 35°C. At 16 hours post infection, infected allantoic fluid was harvested, clarified and titrated using the AOS method for the subsequent passage [<xref ref-type="bibr" rid="ppat.1006796.ref044">44</xref>].</p>
</sec>
<sec id="sec017">
<title>PrimerID library preparation</title>
<p>In experiments using recombinant viruses, hemagglutinin was sequenced using four overlapping amplicons spanning the entire coding sequence. Viral RNA was extracted from allantoic fluid using the QiaAmp Viral RNA Mini Kit. Viral RNA was reverse transcribed with Accuscript Hi-Fi Reverse Transcriptase (Agilent) with the following primers bearing random 12-mer barcodes (All Ns hand-mixed to achieve ~25:25:25:25 ratio): PR8_SV12 Amp 1F 5’-ACACTCTTTCCCTACACGACGCTCTTCCGATCTNNNNNNNNNNNNCAGGAAAATAAAAACAACCAAA ATG-3’, PR8_SV12 Amp 2F 5’-ACACTCTTTCCCTACACGACGCTCTTCCGATCTNNNNNNNNNNNNCACCAAAGAAAGCTCATGGCCC-3’, PR8_SV12 Amp 3F 5’-ACACTCTTTCCCTACACGACGCTCTTCCGATCTNNNNNNNNNNNNCAACACGAAGTGTCAAACACCC -3’, PR8_SV12 Amp 4F 5’-ACACTCTTTCCCTACACGACGCTCTTCCGATCTNNNNNNNNNNNNCAGGATTTCTGGACATTTGGAC -3’. The reverse transcription reactions were purified using the PureLink PCR Purification kit (Invitrogen) using the high-molecular-weight cutoff buffer. First-round PCR was performed using Platinum Taq DNA Polymerase High Fidelity (Invitrogen) with an estimated 10<sup>5</sup> copies of cDNA templates, a universal forward primer (5’-AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACAC-3’) and amplicon-specific reverse primers: PR8_SV12 Amp 1R 5’-GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTNNNNATGGGAGCATGCTGCCGTTA-3’, PR8_SV12 Amp 2R 5’-GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTNNNNGGGAGACTGCTGTTTATAGC-3’, PR8_SV12 Amp 3R 5’-GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTNNNNCAGAGTCCTTTCATTTTCCA-3’, PR8_SV12 Amp 4R 5’-GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTNNNNATATCTCTGAAATTCTAATC-3’.</p>
<p>Sample indices were finally added using KAPA HiFi HotStart PCR Kit, 2.5μL of the first round PCR products and indexed primers (5’- CAAGCAGAAGACGGCATACGAGAT(8-mer sample ID)GTGACTGGAGTTCAGACGTGTG-3’). Amplicons were gel purified using the Qiagen Gel Extraction Kit and quantified on a Nanodrop 1000. Amplicons were pooled into a single library, quantified with the KAPA Library Quantification Kit, and sequenced using the MiSeq Reagent Kit V3 with 325x325 paired-end cycles. The raw sequencing data is available at the NCBI Short Read Archive under accession numbers SRR5428773-SRR5428801.</p>
<p>The primerID library preparation methods used for the original SV12 stock (<xref ref-type="fig" rid="ppat.1006796.g002">Fig 2</xref>) differed from the optimized pipeline described above in several substantive ways. A single amplicon spanning HA amino acids 115 to 258 was generated using an RT primer with a random 10-mer barcode and the Superscript III RT enzyme (Thermo Fisher). Paired-end reads of the amplicon did not overlap, leaving a gap involving codons 184–186. RT primer (HAF381): ACACTCTTTCCCTACACGACGCTCTTCCGA TCTNNNNNNNNNNCAGCTAAGAGAGCAATTGAGCTCAGTGTCATC. Reverse PCR primer HAr813: GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTNNNN GATGCCGGACCCAAAGCCTCTACTCAGTGC. Subsequent library preparation was as outlined above.</p>
</sec>
<sec id="sec018">
<title>PrimerID data analysis</title>
<p>For the sequence analysis of passaging experiments using the recombinant PR8 and SV12 viruses, an optimized analysis pipeline was employed. In this pipeline, the first 4 bases of R2 reads were trimmed using fastx_trimmer from the FASTX Toolkit (v. 0.0.13; <ext-link ext-link-type="uri" xlink:href="http://hannonlab.cshl.edu/fastx_toolkit/" xlink:type="simple">http://hannonlab.cshl.edu/fastx_toolkit/</ext-link>). Overlapping paired-end reads were merged into a single read using PANDAseq (v. 2.9)[<xref ref-type="bibr" rid="ppat.1006796.ref045">45</xref>]. Merged reads were processed using filter_fastq_by_primerid_length.pl to identify and extract the primerID from each read, with options—post CA—removepost, and place the primerID sequence in the sequence id line for each read. Each FASTQ file was split into separate amplicon libraries using Btrim64[<xref ref-type="bibr" rid="ppat.1006796.ref046">46</xref>] with options -u 2 -v 2 -S -B -e 300; a list of primers for each amplicon was also supplied. Off-target sequences were removed with get_majority_block_bam.pl, a wrapper script that maps the reads using BWA MEM (v. 0.7.12-r1039[<xref ref-type="bibr" rid="ppat.1006796.ref047">47</xref>] with options -B 1 -M, converts the output to BAM using Picard SortSam (v. 1.130; <ext-link ext-link-type="uri" xlink:href="http://broadinstitute.github.io/picard/" xlink:type="simple">http://broadinstitute.github.io/picard/</ext-link>), and retains only the reads that have the most common mapped start and stop coordinates using BEDTools (v. 2.19.1)[<xref ref-type="bibr" rid="ppat.1006796.ref048">48</xref>]. Reads were collapsed into consensus sequences using merge_primerid_read_groups.pl with options—ambig 600—min_freq 0.75 to require that the consensus base called makes up at least 75% of the bases for that position within the read group, otherwise an ambiguous base is called. The minimum group size (-m) to use in the merging process was computed for each amplicon within each sample (i.e., each library), using a formula derived for 12 bp primerID length, based on the simulation model proposed by Zhou et al.[<xref ref-type="bibr" rid="ppat.1006796.ref023">23</xref>] in order to reduce the effect of offspring primerID reads from large primerID groups on smaller primerID groups. (To derive the formula for 12 bp primerIDs, the script consensus_cutoff.rb was run with length_of_primer_id set to 12.) If the computed minimum group size was less than 5, then -m was set to 5. Consensus reads were converted to frequency tables for nucleotides, codons, and amino acids at each position within the amplicon using convert_reads_to_amino_acid.pl.</p>
<p>Sequence analysis of the original SV12 stock library (<xref ref-type="fig" rid="ppat.1006796.g002">Fig 2</xref>), generated using a slightly different barcode primer design, substantively differed from the optimized analysis approach described above as follows: PrimerID groups required a minimum of 2 reads, and the intra-sample consensus was used as a tiebreaker.</p>
<p>To determine linkage between high frequency variants (MAF &gt; 0.5%), we performed a Fisher’s exact test for every pair of variants within each replicate and we derived a combined p-value from these individual replicate p-values using Fisher’s method.</p>
<p>All software used for the optimized primerID analysis is available on Github: <ext-link ext-link-type="uri" xlink:href="http://github.com/niaid/primer-id-progs" xlink:type="simple">http://github.com/niaid/primer-id-progs</ext-link>.</p>
<sec id="sec019">
<title>PrimerID-ViVan comparison</title>
<p>Libraries for the parental and passaged viruses were constructed as previously described. Briefly, full-length genomes were amplified from purified viral RNA using a multisegment RT-PCR protocol[<xref ref-type="bibr" rid="ppat.1006796.ref049">49</xref>]. Illumina libraries were then constructed using the Nextera XT DNA Library Prep Kit (Illumina) and sequenced on the Illumina MiSeq platform according the manufacturer’s protocols. Variants for each library were then called with the ViVan pipeline[<xref ref-type="bibr" rid="ppat.1006796.ref024">24</xref>]. Variant frequencies were then compared between primer ID and ViVan calls which passed filter.</p>
</sec>
<sec id="sec020">
<title>Receptor binding analysis</title>
<p>We used Streptavidin Dip and Read Biosensors (ForteBIO, Menlo Park, CA, USA) to measure binding of viruses to sialic acid. Graded amounts of biotinylated 3’-Sialyl lactosamine PAA-biotin aka 3’SLN (GlykoTech) were captured on an avidin coated biosensor. Virus binding experiments were performed by an Octet QKe biolayer interferometer (ForteBio). All of the viruses were diluted in PBS, pH = 7.4, 0.01% BSA, 0.002% Tween-20, (kinetic buffer) for binding to 6’SLN to 1pM in presence of 10μM Oseltamivir (ARC, St. Louis, Mo) and Zanamivir (Moravek Biochemicals, Brea,CA) to block viral NA activity. Binding of virus was measured at 30°C for 10 min followed by a 10 min dissociation measurement.</p>
</sec>
</sec>
</sec>
<sec id="sec021">
<title>Supporting information</title>
<supplementary-material id="ppat.1006796.s001" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006796.s001" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>Variant calling comparison between ViVan and primerID methods.</title>
<p>HA libraries were prepared for both Nextera and amplicon sequencing, and analyzed with ViVan and PrimerID pipelines, respectively. Variant frequencies were compared between the final outputs of both methods for parental wild-type and sequential 12 viruses <bold>(A and B)</bold> and all common variants in three replicates for passage 3 wild-type and sequential 12 viruses <bold>(C and D)</bold>. Red line indicates the expected 1:1 ratio.</p>
<p>(TIFF)</p>
</caption>
</supplementary-material>
<supplementary-material id="ppat.1006796.s002" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006796.s002" xlink:type="simple">
<label>S2 Fig</label>
<caption>
<title>Comparison of background variant frequency levels between ViVan and primerID methods.</title>
<p>(<bold>A, B</bold>) Combined minor amino acid variant frequency is shown for each position of HA amplicon 2 region in SV12 parental sample for unmerged reads (before applying PrimerID), PrimerID consensus reads, and Nextera shotgun sequencing, evaluated by ViVan. <bold>(B)</bold> is a zoomed-in view of <bold>(A)</bold>. (<bold>C, D</bold>) Fold enrichment of variant frequency over median variant frequency for the amplicon region, shown for the same three methods in <bold>(A)</bold> and <bold>(B)</bold>. <bold>(D)</bold> is a zoomed-in view of <bold>(C)</bold>.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="ppat.1006796.s003" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006796.s003" xlink:type="simple">
<label>S3 Fig</label>
<caption>
<title>Non-reducing WB analysis of double glycan addition mutant.</title>
<p>Immunoblot of purified virions as indicated electrophoresed under non-reducing conditions using the HA2 specific mAb RA5-22.</p>
<p>(TIFF)</p>
</caption>
</supplementary-material>
<supplementary-material id="ppat.1006796.s004" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006796.s004" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>PrimerID noise reduction.</title>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="ppat.1006796.s005" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006796.s005" xlink:type="simple">
<label>S2 Table</label>
<caption>
<title>Minor allele frequency background level in primerID and Nextera/ViVan Sequencing.</title>
<p>(TIFF)</p>
</caption>
</supplementary-material>
<supplementary-material id="ppat.1006796.s006" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006796.s006" xlink:type="simple">
<label>S3 Table</label>
<caption>
<title>Pairwise amino acid variant combinations within primerID consensus reads of the original SV12 stock.</title>
<p>Variant amino acids were evaluated pairwise to determine the frequency at which any two substitutions were observed in the same primerID consensus read. The combined counts across the two biological replicates that were sequenced are listed for each pairwise amino acid variant combination.</p>
<p>(TIFF)</p>
</caption>
</supplementary-material>
<supplementary-material id="ppat.1006796.s007" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006796.s007" xlink:type="simple">
<label>S4 Table</label>
<caption>
<title>Specific amino acid substitution combinations observed within primer ID consesus reads in parental and passage 3 recombinant rSV12-HA populations.</title>
<p>Each primerID consensus read was assessed for its inferred amino acid identity at positions 133, 136, 144, 145, and 225 (wild type at each position is NTKNG, respectively). The number of primerID consesus reads that contained the indicated amino acid identities at these positions is listed. Variant amino acids are highlighted in red, and combinations that contain two variant amino acids are in bold face. This table only displays amino acid variant combinations that were observed in at least two primerID concensus reads across all populations examined.</p>
<p>(TIFF)</p>
</caption>
</supplementary-material>
<supplementary-material id="ppat.1006796.s008" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.ppat.1006796.s008" xlink:type="simple">
<label>S5 Table</label>
<caption>
<title>Statistical assessment of linkage between high frequency amino acid substitutions that emerged during rSV12-HA passage.</title>
<p>Combined p-values from three replicate populations as determined by Fisher’s method.</p>
<p>(TIFF)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>Glennys Reynoso provided outstanding technical assistance.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="ppat.1006796.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wiley</surname> <given-names>DC</given-names></name>, <name name-style="western"><surname>Wilson</surname> <given-names>IA</given-names></name>, <name name-style="western"><surname>Skehel</surname> <given-names>JJ</given-names></name>. <article-title>Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation</article-title>. <source>Nature</source>. <year>1981</year> <month>Jan</month> <day>29</day>;<volume>289</volume>(<issue>5796</issue>):<fpage>373</fpage>–<lpage>8</lpage>. <object-id pub-id-type="pmid">6162101</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Caton</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Brownlee</surname> <given-names>GG</given-names></name>, <name name-style="western"><surname>Yewdell</surname> <given-names>JW</given-names></name>, <name name-style="western"><surname>Gerhard</surname> <given-names>W</given-names></name>. <article-title>The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype)</article-title>. <source>Cell</source>. <year>1982</year> <month>Dec</month>;<volume>31</volume>(<issue>2 Pt 1</issue>):<fpage>417</fpage>–<lpage>27</lpage>. <object-id pub-id-type="pmid">6186384</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thyagarajan</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Bloom</surname> <given-names>JD</given-names></name>. <article-title>The inherent mutational tolerance and antigenic evolvability of influenza hemagglutinin</article-title>. <source>eLife</source>. <year>2014</year>;<volume>3</volume>.</mixed-citation></ref>
<ref id="ppat.1006796.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Angeletti</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Gibbs</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Angel</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kosik</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Hickman</surname> <given-names>HD</given-names></name>, <name name-style="western"><surname>Frank</surname> <given-names>GM</given-names></name>, <etal>et al</etal>. <article-title>Defining B cell immunodominance to viruses</article-title>. <source>Nat Immunol</source>. <year>2017</year> <month>Feb</month> <day>13</day>;<volume>18</volume>(<issue>4</issue>):<fpage>456</fpage>–<lpage>63</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ni.3680" xlink:type="simple">10.1038/ni.3680</ext-link></comment> <object-id pub-id-type="pmid">28192417</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Das</surname> <given-names>SR</given-names></name>, <name name-style="western"><surname>Hensley</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>David</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Schmidt</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Gibbs</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Puigbò</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2011</year> <month>Dec</month> <day>20</day>;<volume>108</volume>(<issue>51</issue>):<fpage>E1417</fpage>–<lpage>1422</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.1108754108" xlink:type="simple">10.1073/pnas.1108754108</ext-link></comment> <object-id pub-id-type="pmid">22106257</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kryazhimskiy</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Dushoff</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Bazykin</surname> <given-names>GA</given-names></name>, <name name-style="western"><surname>Plotkin</surname> <given-names>JB</given-names></name>. <article-title>Prevalence of epistasis in the evolution of influenza A surface proteins</article-title>. <source>PLoS Genet</source>. <year>2011</year> <month>Feb</month>;<volume>7</volume>(<issue>2</issue>):<fpage>e1001301</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pgen.1001301" xlink:type="simple">10.1371/journal.pgen.1001301</ext-link></comment> <object-id pub-id-type="pmid">21390205</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yewdell</surname> <given-names>JW</given-names></name>, <name name-style="western"><surname>Taylor</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Yellen</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Caton</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Gerhard</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Bächi</surname> <given-names>T</given-names></name>. <article-title>Mutations in or near the fusion peptide of the influenza virus hemagglutinin affect an antigenic site in the globular region</article-title>. <source>J Virol</source>. <year>1993</year> <month>Feb</month>;<volume>67</volume>(<issue>2</issue>):<fpage>933</fpage>–<lpage>42</lpage>. <object-id pub-id-type="pmid">7678310</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hawman</surname> <given-names>DW</given-names></name>, <name name-style="western"><surname>Fox</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Ashbrook</surname> <given-names>AW</given-names></name>, <name name-style="western"><surname>May</surname> <given-names>NA</given-names></name>, <name name-style="western"><surname>Schroeder</surname> <given-names>KMS</given-names></name>, <name name-style="western"><surname>Torres</surname> <given-names>RM</given-names></name>, <etal>et al</etal>. <article-title>Pathogenic Chikungunya Virus Evades B Cell Responses to Establish Persistence</article-title>. <source>Cell Rep</source>. <year>2016</year> <month>Aug</month> <day>2</day>;<volume>16</volume>(<issue>5</issue>):<fpage>1326</fpage>–<lpage>38</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.celrep.2016.06.076" xlink:type="simple">10.1016/j.celrep.2016.06.076</ext-link></comment> <object-id pub-id-type="pmid">27452455</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Goo</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>VanBlargan</surname> <given-names>LA</given-names></name>, <name name-style="western"><surname>Dowd</surname> <given-names>KA</given-names></name>, <name name-style="western"><surname>Diamond</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>Pierson</surname> <given-names>TC</given-names></name>. <article-title>A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis</article-title>. <source>PLoS Pathog</source>. <year>2017</year> <month>Feb</month>;<volume>13</volume>(<issue>2</issue>):<fpage>e1006178</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.ppat.1006178" xlink:type="simple">10.1371/journal.ppat.1006178</ext-link></comment> <object-id pub-id-type="pmid">28207910</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref010"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Fazekas S, Groth S. Antigenic, Adaptive and Adsorptive Variants of the Influenza a Hemagglutinin. In: Laver WG, Bachmayer H, Weil R, editors. The Influenza Virus Hemagglutinin: Symposium, Baden near Vienna, March 21–23, 1977 [Internet]. Vienna: Springer Vienna; 1978. p. 25–48. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/978-3-7091-4130-4_3" xlink:type="simple">http://dx.doi.org/10.1007/978-3-7091-4130-4_3</ext-link></mixed-citation></ref>
<ref id="ppat.1006796.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yewdell</surname> <given-names>JW</given-names></name>, <name name-style="western"><surname>Caton</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Gerhard</surname> <given-names>W</given-names></name>. <article-title>Selection of influenza A virus adsorptive mutants by growth in the presence of a mixture of monoclonal antihemagglutinin antibodies</article-title>. <source>J Virol</source>. <year>1986</year> <month>Feb</month>;<volume>57</volume>(<issue>2</issue>):<fpage>623</fpage>–<lpage>8</lpage>. <object-id pub-id-type="pmid">2418215</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Temoltzin-Palacios</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Thomas</surname> <given-names>DB</given-names></name>. <article-title>Modulation of immunodominant sites in influenza hemagglutinin compromise antigenic variation and select receptor-binding variant viruses</article-title>. <source>J Exp Med</source>. <year>1994</year> <month>May</month> <day>1</day>;<volume>179</volume>(<issue>5</issue>):<fpage>1719</fpage>–<lpage>24</lpage>. <object-id pub-id-type="pmid">8163950</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hensley</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Das</surname> <given-names>SR</given-names></name>, <name name-style="western"><surname>Bailey</surname> <given-names>AL</given-names></name>, <name name-style="western"><surname>Schmidt</surname> <given-names>LM</given-names></name>, <name name-style="western"><surname>Hickman</surname> <given-names>HD</given-names></name>, <name name-style="western"><surname>Jayaraman</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift</article-title>. <source>Science</source>. <year>2009</year> <month>Oct</month> <day>30</day>;<volume>326</volume>(<issue>5953</issue>):<fpage>734</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.1178258" xlink:type="simple">10.1126/science.1178258</ext-link></comment> <object-id pub-id-type="pmid">19900932</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Skehel</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Stevens</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Daniels</surname> <given-names>RS</given-names></name>, <name name-style="western"><surname>Douglas</surname> <given-names>AR</given-names></name>, <name name-style="western"><surname>Knossow</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Wilson</surname> <given-names>IA</given-names></name>, <etal>et al</etal>. <article-title>A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>1984</year> <month>Mar</month>;<volume>81</volume>(<issue>6</issue>):<fpage>1779</fpage>–<lpage>83</lpage>. <object-id pub-id-type="pmid">6584912</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wei</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Decker</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Hui</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Kappes</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>X</given-names></name>, <etal>et al</etal>. <article-title>Antibody neutralization and escape by HIV-1</article-title>. <source>Nature</source>. <year>2003</year> <month>Mar</month> <day>20</day>;<volume>422</volume>(<issue>6929</issue>):<fpage>307</fpage>–<lpage>12</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature01470" xlink:type="simple">10.1038/nature01470</ext-link></comment> <object-id pub-id-type="pmid">12646921</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>O’Donnell</surname> <given-names>CD</given-names></name>, <name name-style="western"><surname>Wright</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Vogel</surname> <given-names>LN</given-names></name>, <name name-style="western"><surname>Wei</surname> <given-names>C-J</given-names></name>, <name name-style="western"><surname>Nabel</surname> <given-names>GJ</given-names></name>, <name name-style="western"><surname>Subbarao</surname> <given-names>K</given-names></name>. <article-title>Effect of priming with H1N1 influenza viruses of variable antigenic distances on challenge with 2009 pandemic H1N1 virus</article-title>. <source>J Virol</source>. <year>2012</year> <month>Aug</month>;<volume>86</volume>(<issue>16</issue>):<fpage>8625</fpage>–<lpage>33</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.00147-12" xlink:type="simple">10.1128/JVI.00147-12</ext-link></comment> <object-id pub-id-type="pmid">22674976</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Medina</surname> <given-names>RA</given-names></name>, <name name-style="western"><surname>Stertz</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Manicassamy</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Zimmermann</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Sun</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Albrecht</surname> <given-names>RA</given-names></name>, <etal>et al</etal>. <article-title>Glycosylations in the globular head of the hemagglutinin protein modulate the virulence and antigenic properties of the H1N1 influenza viruses</article-title>. <source>Sci Transl Med</source>. <year>2013</year> <month>May</month> <day>29</day>;<volume>5</volume>(<issue>187</issue>):<fpage>187ra70</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/scitranslmed.3005996" xlink:type="simple">10.1126/scitranslmed.3005996</ext-link></comment> <object-id pub-id-type="pmid">23720581</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Helle</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Goffard</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Morel</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Duverlie</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>McKeating</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Keck</surname> <given-names>Z-Y</given-names></name>, <etal>et al</etal>. <article-title>The neutralizing activity of anti-hepatitis C virus antibodies is modulated by specific glycans on the E2 envelope protein</article-title>. <source>J Virol</source>. <year>2007</year> <month>Aug</month>;<volume>81</volume>(<issue>15</issue>):<fpage>8101</fpage>–<lpage>11</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.00127-07" xlink:type="simple">10.1128/JVI.00127-07</ext-link></comment> <object-id pub-id-type="pmid">17522218</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lennemann</surname> <given-names>NJ</given-names></name>, <name name-style="western"><surname>Rhein</surname> <given-names>BA</given-names></name>, <name name-style="western"><surname>Ndungo</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Chandran</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Qiu</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Maury</surname> <given-names>W</given-names></name>. <article-title>Comprehensive functional analysis of N-linked glycans on Ebola virus GP1</article-title>. <source>mBio</source>. <year>2014</year>;<volume>5</volume>(<issue>1</issue>):<fpage>e00862</fpage>–<lpage>00813</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/mBio.00862-13" xlink:type="simple">10.1128/mBio.00862-13</ext-link></comment> <object-id pub-id-type="pmid">24473128</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Underwood</surname> <given-names>PA</given-names></name>, <name name-style="western"><surname>Skehel</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Wiley</surname> <given-names>DC</given-names></name>. <article-title>Receptor-binding characteristics of monoclonal antibody-selected antigenic variants of influenza virus</article-title>. <source>J Virol</source>. <year>1987</year> <month>Jan</month>;<volume>61</volume>(<issue>1</issue>):<fpage>206</fpage>–<lpage>8</lpage>. <object-id pub-id-type="pmid">3783824</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Das</surname> <given-names>SR</given-names></name>, <name name-style="western"><surname>Hensley</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Ince</surname> <given-names>WL</given-names></name>, <name name-style="western"><surname>Brooke</surname> <given-names>CB</given-names></name>, <name name-style="western"><surname>Subba</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Delboy</surname> <given-names>MG</given-names></name>, <etal>et al</etal>. <article-title>Defining influenza A virus hemagglutinin antigenic drift by sequential monoclonal antibody selection</article-title>. <source>Cell Host Microbe</source>. <year>2013</year> <month>Mar</month> <day>13</day>;<volume>13</volume>(<issue>3</issue>):<fpage>314</fpage>–<lpage>23</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.chom.2013.02.008" xlink:type="simple">10.1016/j.chom.2013.02.008</ext-link></comment> <object-id pub-id-type="pmid">23498956</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jabara</surname> <given-names>CB</given-names></name>, <name name-style="western"><surname>Jones</surname> <given-names>CD</given-names></name>, <name name-style="western"><surname>Roach</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Anderson</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Swanstrom</surname> <given-names>R</given-names></name>. <article-title>Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2011</year> <month>Dec</month> <day>13</day>;<volume>108</volume>(<issue>50</issue>):<fpage>20166</fpage>–<lpage>71</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.1110064108" xlink:type="simple">10.1073/pnas.1110064108</ext-link></comment> <object-id pub-id-type="pmid">22135472</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhou</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Jones</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Mieczkowski</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Swanstrom</surname> <given-names>R</given-names></name>. <article-title>Primer ID Validates Template Sampling Depth and Greatly Reduces the Error Rate of Next-Generation Sequencing of HIV-1 Genomic RNA Populations</article-title>. <source>J Virol</source>. <year>2015</year> <month>Aug</month>;<volume>89</volume>(<issue>16</issue>):<fpage>8540</fpage>–<lpage>55</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.00522-15" xlink:type="simple">10.1128/JVI.00522-15</ext-link></comment> <object-id pub-id-type="pmid">26041299</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Isakov</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Borderia</surname> <given-names>AV</given-names></name>, <name name-style="western"><surname>Golan</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Hamenahem</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Celniker</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Yoffe</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Deep sequencing analysis of viral infection and evolution allows rapid and detailed characterization of viral mutant spectrum</article-title>. <source>Bioinformatics</source>. <year>2015</year> <month>Jul</month> <day>1</day>;<volume>31</volume>(<issue>13</issue>):<fpage>2141</fpage>–<lpage>50</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/bioinformatics/btv101" xlink:type="simple">10.1093/bioinformatics/btv101</ext-link></comment> <object-id pub-id-type="pmid">25701575</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McCrone</surname> <given-names>JT</given-names></name>, <name name-style="western"><surname>Lauring</surname> <given-names>AS</given-names></name>. <article-title>Measurements of Intrahost Viral Diversity Are Extremely Sensitive to Systematic Errors in Variant Calling</article-title>. <name name-style="western"><surname>Dermody</surname> <given-names>TS</given-names></name>, editor. <source>J Virol</source>. <year>2016</year> <month>Aug</month> <day>1</day>;<volume>90</volume>(<issue>15</issue>):<fpage>6884</fpage>–<lpage>95</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.00667-16" xlink:type="simple">10.1128/JVI.00667-16</ext-link></comment> <object-id pub-id-type="pmid">27194763</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Aebi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Bernasconi</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Clerc</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Molinari</surname> <given-names>M</given-names></name>. <article-title>N-glycan structures: recognition and processing in the ER</article-title>. <source>Trends Biochem Sci</source>. <year>2010</year> <month>Feb</month>;<volume>35</volume>(<issue>2</issue>):<fpage>74</fpage>–<lpage>82</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.tibs.2009.10.001" xlink:type="simple">10.1016/j.tibs.2009.10.001</ext-link></comment> <object-id pub-id-type="pmid">19853458</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Doud</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Bloom</surname> <given-names>J</given-names></name>. <article-title>Accurate Measurement of the Effects of All Amino-Acid Mutations on Influenza Hemagglutinin</article-title>. <source>Viruses</source>. <year>2016</year> <month>Jun</month> <day>3</day>;<volume>8</volume>(<issue>6</issue>):<fpage>155</fpage>.</mixed-citation></ref>
<ref id="ppat.1006796.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Boni</surname> <given-names>MF</given-names></name>, <name name-style="western"><surname>Zhou</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Taubenberger</surname> <given-names>JK</given-names></name>, <name name-style="western"><surname>Holmes</surname> <given-names>EC</given-names></name>. <article-title>Homologous Recombination Is Very Rare or Absent in Human Influenza A Virus</article-title>. <source>J Virol</source>. <year>2008</year> <month>May</month> <day>15</day>;<volume>82</volume>(<issue>10</issue>):<fpage>4807</fpage>–<lpage>11</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.02683-07" xlink:type="simple">10.1128/JVI.02683-07</ext-link></comment> <object-id pub-id-type="pmid">18353939</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Miralles</surname> <given-names>R</given-names></name>. <article-title>Clonal Interference and the Evolution of RNA Viruses</article-title>. <source>Science</source>. <year>1999</year> <month>Sep</month> <day>10</day>;<volume>285</volume>(<issue>5434</issue>):<fpage>1745</fpage>–<lpage>7</lpage>. <object-id pub-id-type="pmid">10481012</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Strelkowa</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Lässig</surname> <given-names>M</given-names></name>. <article-title>Clonal interference in the evolution of influenza</article-title>. <source>Genetics</source>. <year>2012</year> <month>Oct</month>;<volume>192</volume>(<issue>2</issue>):<fpage>671</fpage>–<lpage>82</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1534/genetics.112.143396" xlink:type="simple">10.1534/genetics.112.143396</ext-link></comment> <object-id pub-id-type="pmid">22851649</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Heaton</surname> <given-names>NS</given-names></name>, <name name-style="western"><surname>Sachs</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>C-J</given-names></name>, <name name-style="western"><surname>Hai</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Palese</surname> <given-names>P</given-names></name>. <article-title>Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2013</year> <month>Dec</month> <day>10</day>;<volume>110</volume>(<issue>50</issue>):<fpage>20248</fpage>–<lpage>53</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.1320524110" xlink:type="simple">10.1073/pnas.1320524110</ext-link></comment> <object-id pub-id-type="pmid">24277853</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Visher</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Whitefield</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>McCrone</surname> <given-names>JT</given-names></name>, <name name-style="western"><surname>Fitzsimmons</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Lauring</surname> <given-names>AS</given-names></name>. <article-title>The Mutational Robustness of Influenza A Virus</article-title>. <source>PLoS Pathog</source>. <year>2016</year> <month>Aug</month>;<volume>12</volume>(<issue>8</issue>):<fpage>e1005856</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.ppat.1005856" xlink:type="simple">10.1371/journal.ppat.1005856</ext-link></comment> <object-id pub-id-type="pmid">27571422</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>de Visser</surname> <given-names>JAGM</given-names></name>, <name name-style="western"><surname>Hermisson</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Wagner</surname> <given-names>GP</given-names></name>, <name name-style="western"><surname>Ancel Meyers</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Bagheri-Chaichian</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Blanchard</surname> <given-names>JL</given-names></name>, <etal>et al</etal>. <article-title>Perspective: Evolution and detection of genetic robustness</article-title>. <source>Evol Int J Org Evol</source>. <year>2003</year> <month>Sep</month>;<volume>57</volume>(<issue>9</issue>):<fpage>1959</fpage>–<lpage>72</lpage>.</mixed-citation></ref>
<ref id="ppat.1006796.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lauring</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Frydman</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Andino</surname> <given-names>R</given-names></name>. <article-title>The role of mutational robustness in RNA virus evolution</article-title>. <source>Nat Rev Microbiol</source>. <year>2013</year> <month>May</month>;<volume>11</volume>(<issue>5</issue>):<fpage>327</fpage>–<lpage>36</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrmicro3003" xlink:type="simple">10.1038/nrmicro3003</ext-link></comment> <object-id pub-id-type="pmid">23524517</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gong</surname> <given-names>LI</given-names></name>, <name name-style="western"><surname>Suchard</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Bloom</surname> <given-names>JD</given-names></name>. <article-title>Stability-mediated epistasis constrains the evolution of an influenza protein</article-title>. <source>eLife</source>. <year>2013</year>;<volume>2</volume>:<fpage>e00631</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7554/eLife.00631" xlink:type="simple">10.7554/eLife.00631</ext-link></comment> <object-id pub-id-type="pmid">23682315</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hensley</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Das</surname> <given-names>SR</given-names></name>, <name name-style="western"><surname>Gibbs</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Bailey</surname> <given-names>AL</given-names></name>, <name name-style="western"><surname>Schmidt</surname> <given-names>LM</given-names></name>, <name name-style="western"><surname>Bennink</surname> <given-names>JR</given-names></name>, <etal>et al</etal>. <article-title>Influenza A virus hemagglutinin antibody escape promotes neuraminidase antigenic variation and drug resistance</article-title>. <source>PloS One</source>. <year>2011</year>;<volume>6</volume>(<issue>2</issue>):<fpage>e15190</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0015190" xlink:type="simple">10.1371/journal.pone.0015190</ext-link></comment> <object-id pub-id-type="pmid">21364978</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Neverov</surname> <given-names>AD</given-names></name>, <name name-style="western"><surname>Kryazhimskiy</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Plotkin</surname> <given-names>JB</given-names></name>, <name name-style="western"><surname>Bazykin</surname> <given-names>GA</given-names></name>. <article-title>Coordinated Evolution of Influenza A Surface Proteins</article-title>. <source>PLoS Genet</source>. <year>2015</year> <month>Aug</month>;<volume>11</volume>(<issue>8</issue>):<fpage>e1005404</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pgen.1005404" xlink:type="simple">10.1371/journal.pgen.1005404</ext-link></comment> <object-id pub-id-type="pmid">26247472</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Koelle</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Cobey</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Grenfell</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Pascual</surname> <given-names>M</given-names></name>. <article-title>Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans</article-title>. <source>Science</source>. <year>2006</year> <month>Dec</month> <day>22</day>;<volume>314</volume>(<issue>5807</issue>):<fpage>1898</fpage>–<lpage>903</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.1132745" xlink:type="simple">10.1126/science.1132745</ext-link></comment> <object-id pub-id-type="pmid">17185596</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Weinreich</surname> <given-names>DM</given-names></name>, <name name-style="western"><surname>Delaney</surname> <given-names>NF</given-names></name>, <name name-style="western"><surname>Depristo</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Hartl</surname> <given-names>DL</given-names></name>. <article-title>Darwinian evolution can follow only very few mutational paths to fitter proteins</article-title>. <source>Science</source>. <year>2006</year> <month>Apr</month> <day>7</day>;<volume>312</volume>(<issue>5770</issue>):<fpage>111</fpage>–<lpage>4</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1126/science.1123539" xlink:type="simple">10.1126/science.1123539</ext-link></comment> <object-id pub-id-type="pmid">16601193</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brooke</surname> <given-names>CB</given-names></name>, <name name-style="western"><surname>Ince</surname> <given-names>WL</given-names></name>, <name name-style="western"><surname>Wei</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Bennink</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Yewdell</surname> <given-names>JW</given-names></name>. <article-title>Influenza A virus nucleoprotein selectively decreases neuraminidase gene-segment packaging while enhancing viral fitness and transmissibility</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2014</year> <month>Nov</month> <day>25</day>;<volume>111</volume>(<issue>47</issue>):<fpage>16854</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.1415396111" xlink:type="simple">10.1073/pnas.1415396111</ext-link></comment> <object-id pub-id-type="pmid">25385602</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Acevedo</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Andino</surname> <given-names>R</given-names></name>. <article-title>Library preparation for highly accurate population sequencing of RNA viruses</article-title>. <source>Nat Protoc</source>. <year>2014</year> <month>Jul</month>;<volume>9</volume>(<issue>7</issue>):<fpage>1760</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nprot.2014.118" xlink:type="simple">10.1038/nprot.2014.118</ext-link></comment> <object-id pub-id-type="pmid">24967624</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Acevedo</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Brodsky</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Andino</surname> <given-names>R</given-names></name>. <article-title>Mutational and fitness landscapes of an RNA virus revealed through population sequencing</article-title>. <source>Nature</source>. <year>2014</year> <month>Jan</month> <day>30</day>;<volume>505</volume>(<issue>7485</issue>):<fpage>686</fpage>–<lpage>90</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature12861" xlink:type="simple">10.1038/nature12861</ext-link></comment> <object-id pub-id-type="pmid">24284629</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yewdell</surname> <given-names>JW</given-names></name>. <article-title>Monoclonal antibodies specific for discontinuous epitopes direct refolding of influenza A virus hemagglutinin</article-title>. <source>Mol Immunol</source>. <year>2010</year> <month>Feb</month>;<volume>47</volume>(<issue>5</issue>):<fpage>1132</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molimm.2009.10.023" xlink:type="simple">10.1016/j.molimm.2009.10.023</ext-link></comment> <object-id pub-id-type="pmid">20047763</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fazekas De St Groth</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>White</surname> <given-names>DO</given-names></name>. <article-title>An improved assay for the infectivity of in influenza viruses</article-title>. <source>J Hyg (Lond)</source>. <year>1958</year> <month>Mar</month>;<volume>56</volume>(<issue>1</issue>):<fpage>151</fpage>–<lpage>62</lpage>.</mixed-citation></ref>
<ref id="ppat.1006796.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Masella</surname> <given-names>AP</given-names></name>, <name name-style="western"><surname>Bartram</surname> <given-names>AK</given-names></name>, <name name-style="western"><surname>Truszkowski</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Brown</surname> <given-names>DG</given-names></name>, <name name-style="western"><surname>Neufeld</surname> <given-names>JD</given-names></name>. <article-title>PANDAseq: paired-end assembler for illumina sequences</article-title>. <source>BMC Bioinformatics</source>. <year>2012</year> <month>Feb</month> <day>14</day>;<volume>13</volume>:<fpage>31</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-2105-13-31" xlink:type="simple">10.1186/1471-2105-13-31</ext-link></comment> <object-id pub-id-type="pmid">22333067</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kong</surname> <given-names>Y</given-names></name>. <article-title>Btrim: a fast, lightweight adapter and quality trimming program for next-generation sequencing technologies</article-title>. <source>Genomics</source>. <year>2011</year> <month>Aug</month>;<volume>98</volume>(<issue>2</issue>):<fpage>152</fpage>–<lpage>3</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ygeno.2011.05.009" xlink:type="simple">10.1016/j.ygeno.2011.05.009</ext-link></comment> <object-id pub-id-type="pmid">21651976</object-id></mixed-citation></ref>
<ref id="ppat.1006796.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Durbin</surname> <given-names>R</given-names></name>. <article-title>Fast and accurate short read alignment with Burrows-Wheeler transform</article-title>. <source>Bioinforma Oxf Engl</source>. <year>2009</year> <month>Jul</month> <day>15</day>;<volume>25</volume>(<issue>14</issue>):<fpage>1754</fpage>–<lpage>60</lpage>.</mixed-citation></ref>
<ref id="ppat.1006796.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Quinlan</surname> <given-names>AR</given-names></name>, <name name-style="western"><surname>Hall</surname> <given-names>IM</given-names></name>. <article-title>BEDTools: a flexible suite of utilities for comparing genomic features</article-title>. <source>Bioinforma Oxf Engl</source>. <year>2010</year> <month>Mar</month> <day>15</day>;<volume>26</volume>(<issue>6</issue>):<fpage>841</fpage>–<lpage>2</lpage>.</mixed-citation></ref>
<ref id="ppat.1006796.ref049"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhou</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Donnelly</surname> <given-names>ME</given-names></name>, <name name-style="western"><surname>Scholes</surname> <given-names>DT</given-names></name>, <name name-style="western"><surname>St George</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Hatta</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kawaoka</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses</article-title>. <source>J Virol</source>. <year>2009</year> <month>Oct</month>;<volume>83</volume>(<issue>19</issue>):<fpage>10309</fpage>–<lpage>13</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.01109-09" xlink:type="simple">10.1128/JVI.01109-09</ext-link></comment> <object-id pub-id-type="pmid">19605485</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>